Acrivon Therapeutics, Inc.
(Note: Acrivon Therapeutics priced its IPO on Monday night, Nov. 14, 2022, at $12.50 – far below its price range of $16 to $18 – and priced 7.55 million shares (7,550,000 shares) to raise $94.38 million. Acrivon Therapeutics filed a Free Writing Prospectus on Monday night, Nov. 14, 2022, that showed only three names – […]
October 17, 2022 Read More